The LMCE 2023 Organizing Committee cordially invites you to submit abstracts for oral and poster presentations. All congress abstracts must be submitted online via the "Online Submission System.“ Submitted abstracts will be reviewed by the Scientific Program Committee. The presentation type may possibly be changed following review by the Scientific Committee. Abstract submission does not constitute registration for the congress and presenters are required to register for the conference separately. Please read the guidelines carefully before submitting your abstract.

Important Dates

  • -Deadline for Abstract Submission: July 10, 2023, 23:59 (KST)
  • -Notification of Abstract Acceptance: From Wednesday, August 16, 2023
  • * Please note that there will be no further abstract submission extensions for LMCE 2023, so please submit your abstract by the deadline.

Steps for Abstract Submission

  • Step 1 Review abstract topics and guidelines carefully
  • Step 2 Click the abstract submission button
  • Step 3 Sign up or log in
  • Step 4 Fill out submitter info
  • Step 5 Complete abstract
    submission and author info sections
  • Step 6 Check confirmation Letter of your submission

Abstract Submission Topics

No. Topic Sub Topic
1 Clinical Chemistry Arterial blood gas analysis and electrolytes Method evaluation/reference interval
Congenital metabolic disorders Proteins
Endocrine function tests Sampling, storage, and physiological variations
Intermediate metabolites and inorganic ions Therapeutic drug monitoring and toxicology
Kidney function and urinalysis Tumor markers
Liver/biliary function test Others
2 Clinical Microbiology Acid-fast bacilli Infection control
Antimicrobials and sensitivity test Mycoplasma and rickettsia
Automated microbial identification/instrument Virus
Bacteria Others
3 Diagnostic Genetics Cancer genetics Infectious diseases
Hereditary disorders Others
4 Diagnostic Hematology Automated analyzers WBC disorders-benign
Coagulation and hemostasis WBC disorders-malignant
Platelet disorders Others
RBC disorders
5 Diagnostic Immunology Allergic disease Immunodeficiency
Autoimmune disease Inflammatory mediators
Cancer immunology Infection immunology
HLA and transplantation Others
6 Transfusion Medicine Blood components Therapeutic apheresis/cell therapy
Blood typing Transfusion reaction
Hematopoietic stem cell Transfusion therapy
RBC antigen/antibody Others
7 General Laboratory Medicine Laboratory informatics Others
Point-of-care test

Abstract Submission Guidelines

Theses guidelines are for general participants, not invited speakers.
  • -The content must not have been published previously in a copyrighted, peer reviewed journal (such as Clinical Chemistry) by any one or more of the submitting authors.
  • -All abstracts must be submitted online prior to July 10, 2023, 23:59 (KST).
  • -Abstracts must be written in clear English and limited to 400 words.
  • -An abstract consists of a title, author name ‘s and affiliation, the text of the submission and keyword
Title Capitalize the first letter of each word
Author Information
  • -Name: Write first and family name(s) in full.
  • -Affiliation should be structured as follows: Department, Institution, City, Country
  • -Degrees or titles such as MD after an author’s name must be deleted
Abstract Body In case of Original Article, the abstract body text should be structured chronologically into four sections:
Background, Methods, Results, Conclusions
Keywords No more than 6 keywords which the first word begins with a capital letter.
Tables and Images No tables or images are allowed.
Before you click the “submit” button, please review the following information.
  • -No additional proofreading or corrections will be allowed after the submission deadline. It is the responsibility of the authors to ensure that their text does not contain typos or grammatical errors.
  • -Authors have the option of choosing their presentation type (oral presentation or poster presentation). However, the scientific program committee will make the final decision after review.
  • -Acknowledgment of your submission will be sent to the e-mail address provided by the abstract submitting author. If you do not receive this e-mail confirmation, it means we have not received your abstract. If you are sure you have submitted it, check to make sure you sent it to the correct e-mail address.
  • -The e-mail you provided us will be used to notify you of the acceptance and to send you updated information. If you have any inquiries, please contact the secretariat at info@lmce-kslm.org.

Notification of Acceptance

  • -All submitted abstracts will be reviewed by the Scientific Program Committee according to reviewing procedures.
  • -Notification of acceptance will be sent by e-mail to corresponding, presenting and abstract submitting authors from August 7, 2023.
  • -The presenting author should reply to the acceptance notification for confirmation of attendance.

Abstract Withdrawal

  • -If the presenting author of an accepted abstract does not register by September 20, 2023, the abstract will be automatically withdrawn from the final program.
  • -If you have to withdraw an abstract, please notify the secretariat (info@lmce-kslm.org) in writing as soon as possible.
If you have any inquiries regarding abstract submission, please contact the Secretariat.
(E-mail: info@lmce-kslm.org   Tel. +82-70-4895-6129)